Realizing the potential of decentralized clinical trials in oncology

Considering opportuities to decentralize oncology trials or parts of trials can help patient recruitment and participation.

Designing patient-centric ePROs to reduce patient burden and promote study compliance in a multinational Phase III oncology trial

Designing a patient-centric approach in a Phase III NSCLC Phase III trial.

San Francisco Bay Area biotech advances Phase I-II cancer immunotherapy trial with Fortrea

Rigorous site selection and recruitment to accomplish patient enrollment with extensive inclusion/exclusion criteria.

How Fortrea brought an agile partnership approach to delivering a new oncology model

Fortrea delivery of two trials in parallel that grew to suite of studies.

Immuno-oncology publication spotlight: our top recent peer-reviewed journal articles featuring Fortrea oncologists discussing immuno-oncology drug development

The Fortrea team has over 60 oncologists, many often contribute to immuno-oncology peer-reviewed journal articles. Read the articles here.

Raising the bar: How our Ophthalmology Academy transforms clinical trials

Clinical Trial Site Support Solutions

Through our solutions to support clinical trial sites, we offer flexible resources to bridge gaps in your operations.

Phase I Alzheimer’s Disease

Applying a patient- and site-centric approach in an early Phase I Alzheimer’s Disease study